|
Volumn 107, Issue 9, 2011, Pages 1507-1508
|
Revolution or evolution in erectile dysfunction?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GENERIC DRUG;
PHOSPHODIESTERASE INHIBITOR;
SILDENAFIL;
TADALAFIL;
VARDENAFIL;
COST EFFECTIVENESS ANALYSIS;
DRUG APPROVAL;
DRUG CONTRAINDICATION;
DRUG COST;
DRUG INDUSTRY;
DRUG MARKETING;
ERECTILE DYSFUNCTION;
NOTE;
PATENT;
PRIORITY JOURNAL;
PROSTATE HYPERTROPHY;
PUBLICATION;
DRUGS, GENERIC;
ERECTILE DYSFUNCTION;
HUMANS;
MALE;
PHOSPHODIESTERASE 5 INHIBITORS;
PIPERAZINES;
PURINES;
SULFONES;
|
EID: 79955432165
PISSN: 14644096
EISSN: 1464410X
Source Type: Journal
DOI: 10.1111/j.1464-410X.2011.10302.x Document Type: Note |
Times cited : (1)
|
References (0)
|